carmustine has been researched along with Stomatitis in 12 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
Stomatitis: INFLAMMATION of the soft tissues of the MOUTH, such as MUCOSA; PALATE; GINGIVA; and LIP.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The Prospective Oral Mucositis Audit was an observational study in 197 patients with multiple myeloma (MM) or non-Hodgkin's lymphoma (NHL) undergoing, respectively, high-dose melphalan or BEAM chemotherapy and autologous SCT at 25 European centres." | 3.75 | The Prospective Oral Mucositis Audit: relationship of severe oral mucositis with clinical and medical resource use outcomes in patients receiving high-dose melphalan or BEAM-conditioning chemotherapy and autologous SCT. ( Bacon, P; Blijlevens, N; D'Addio, A; Einsele, H; Maertens, J; McCann, S; Niederwieser, D; Quinn, B; Rabitsch, W; Roosaar, A; Ruutu, T; Schouten, H; Schwenkglenks, M; Stone, R; Vorkurka, S, 2009) |
| "the severity of oral mucositis was less than would be expected in these patients without anti-mucositis therapy." | 2.72 | Palifermin for oral mucositis in the high-dose chemotherapy and stem cell transplant setting: the Royal Adelaide Hospital Cancer Centre experience. ( Horvath, N; Keefe, D; Lees, J, 2006) |
| "Fifteen patients with Hodgkin's or non-Hodgkin's lymphoma receiving HD conditioning chemotherapy and autologous SCT were assessed with respect to oral pain and severity of stomatitis on day -6, 0, +5 to +7, +13 to +15, and +100." | 1.37 | Association of HSV reactivation and pro-inflammatory cytokine levels with the severity of stomatitis after BEAM chemotherapy and autologous SCT. ( Cornely, OA; Keulertz, C; Lövenich, H; Rüping, MJ; Söhngen, D; Vehreschild, JJ; Wieland, U, 2011) |
| "The Prospective Oral Mucositis Audit assessed the incidence, duration, and determinants of severe oral mucositis (OM; WHO oral toxicity scale grades 3 to 4) in patients with multiple myeloma (MM) or non-Hodgkin's lymphoma (NHL) receiving high-dose conditioning chemotherapy before autologous stem-cell transplantation." | 1.35 | Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy--European Blood and Marrow Transplantation Mucositis Advisory Group. ( Bacon, P; Blijlevens, N; D'Addio, A; Einsele, H; Maertens, J; McCann, S; Niederwieser, D; Quinn, B; Rabitsch, W; Roosaar, A; Ruutu, T; Schouten, H; Schwenkglenks, M; Stone, R; Vokurka, S, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 8 (66.67) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McCann, S | 2 |
| Schwenkglenks, M | 2 |
| Bacon, P | 2 |
| Einsele, H | 2 |
| D'Addio, A | 2 |
| Maertens, J | 2 |
| Niederwieser, D | 2 |
| Rabitsch, W | 2 |
| Roosaar, A | 2 |
| Ruutu, T | 2 |
| Schouten, H | 2 |
| Stone, R | 2 |
| Vorkurka, S | 1 |
| Quinn, B | 2 |
| Blijlevens, N | 2 |
| Hunter, A | 1 |
| Mahendra, P | 1 |
| Wilson, K | 1 |
| Fields, P | 1 |
| Cook, G | 1 |
| Peniket, A | 1 |
| Crawley, C | 1 |
| Hickling, R | 1 |
| Marcus, R | 1 |
| Rüping, MJ | 1 |
| Keulertz, C | 1 |
| Vehreschild, JJ | 1 |
| Lövenich, H | 1 |
| Söhngen, D | 1 |
| Wieland, U | 1 |
| Cornely, OA | 1 |
| Vokurka, S | 4 |
| Bystricka, E | 3 |
| Scudlova, J | 3 |
| Mazur, E | 1 |
| Visokaiova, M | 2 |
| Vasilieva, E | 1 |
| Brandejsova, R | 1 |
| Chvojkova, I | 1 |
| Vrabcova, M | 1 |
| Vitkova, J | 1 |
| Mjartanova, D | 1 |
| Vodickova, M | 1 |
| Bockova, J | 2 |
| Streinerova, K | 1 |
| Waśko-Grabowska, A | 1 |
| Rzepecki, P | 1 |
| Oborska, S | 1 |
| Barzał, J | 1 |
| Gawroński, K | 1 |
| Młot, B | 1 |
| Szczylik, C | 1 |
| Koza, V | 2 |
| Pavlicová, V | 2 |
| Valentová, D | 2 |
| Misaniová, L | 2 |
| Prince, HM | 1 |
| Regester, G | 1 |
| Gates, P | 1 |
| Jablonskis, L | 1 |
| Seymour, JF | 1 |
| Lillie, K | 1 |
| West, R | 1 |
| Wolf, M | 1 |
| Januszewicz, H | 1 |
| Belford, D | 1 |
| Keefe, D | 1 |
| Lees, J | 1 |
| Horvath, N | 1 |
| Strobel, ES | 1 |
| Bauchmüller, K | 1 |
| Ihorst, G | 1 |
| Engelhardt, M | 1 |
| Vaughan, WP | 1 |
| Kris, E | 1 |
| Vose, J | 1 |
| Bierman, PJ | 1 |
| Gwilt, P | 1 |
| Armitage, JO | 1 |
1 review available for carmustine and Stomatitis
| Article | Year |
|---|---|
Frequency, severity and risk factors for oral mucositis after BEAM conditioning and autologous peripheral blood stem cell transplantation: a single center analysis and review of the literature.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabi | 2007 |
6 trials available for carmustine and Stomatitis
| Article | Year |
|---|---|
Treatment of oral mucositis after peripheral blood SCT with ATL-104 mouthwash: results from a randomized, double-blind, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Dou | 2009 |
The risk factors for oral mucositis and the effect of cryotherapy in patients after the BEAM and HD-l-PAM 200 mg/m(2) autologous hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cryotherapy; Cy | 2011 |
Efficiency of supersaturated calcium phosphate mouth rinse treatment in patients receiving high-dose melphalan or BEAM prior to autologous blood stem cell transplantation: a single-center experience.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Calcium Phosphates; Carmustine; Cytarabine; E | 2011 |
The comparative effects of povidone-iodine and normal saline mouthwashes on oral mucositis in patients after high-dose chemotherapy and APBSCT--results of a randomized multicentre study.
Topics: Adult; Aged; Anti-Infective Agents, Local; Antineoplastic Combined Chemotherapy Protocols; Carmustin | 2005 |
Palifermin for oral mucositis in the high-dose chemotherapy and stem cell transplant setting: the Royal Adelaide Hospital Cancer Centre experience.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cancer Care | 2006 |
Phase I/II study incorporating intravenous hydroxyurea into high-dose chemotherapy for patients with primary refractory or relapsed and refractory intermediate-grade and high-grade malignant lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carm | 1995 |
5 other studies available for carmustine and Stomatitis
| Article | Year |
|---|---|
The Prospective Oral Mucositis Audit: relationship of severe oral mucositis with clinical and medical resource use outcomes in patients receiving high-dose melphalan or BEAM-conditioning chemotherapy and autologous SCT.
Topics: Adult; Aged; Analgesics, Opioid; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protoco | 2009 |
Association of HSV reactivation and pro-inflammatory cytokine levels with the severity of stomatitis after BEAM chemotherapy and autologous SCT.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Cytokines; Female; He | 2011 |
A phase Ib clinical trial of PV701, a milk-derived protein extract, for the prevention and treatment of oral mucositis in patients undergoing high-dose BEAM chemotherapy.
Topics: Adult; Aged; Animals; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Carmust | 2005 |
Higher incidence of chemotherapy induced oral mucositis in females: a supplement of multivariate analysis to a randomized multicentre study.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carmu | 2006 |
Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy--European Blood and Marrow Transplantation Mucositis Advisory Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine | 2008 |